Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.4K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Higher Mental Functions of the Brain: Language01:10

Higher Mental Functions of the Brain: Language

2.4K
Language is a system of communication that allows the expression of thoughts, ideas, and feelings. The brain processes language in both hemispheres.
Language formation and comprehension take place in the dominant hemisphere. The dominant hemisphere is responsible for understanding the meaning of spoken, written, or sign language, as well as the ability to communicate. For most people, the left hemisphere is the dominant one. The right hemisphere, then, gives tone and emotional context to the...
2.4K
Long-term Potentiation01:35

Long-term Potentiation

57.1K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
57.1K
Long-term Potentiation01:25

Long-term Potentiation

3.1K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recruitment strategies in a diverse Parkinson's disease cohort: lessons from the East London Parkinson's Disease Project.

BMJ neurology open·2026
Same author

Lifestyle interventions for dementia prevention in low- and middle-income countries: a systematic review.

BMJ global health·2026
Same author

Communication Partner Training Practices for People With Aphasia Among Latin American Speech and Language Therapists: A Survey of Implementation Barriers and Facilitators.

International journal of language & communication disorders·2026
Same author

The contribution of apolipoprotein E genetic variation to dementia risk in British South Asians.

Brain communications·2026
Same author

Non-verbal dichotic listening: A new cognitive hearing test for dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The speech and language therapist's role in supporting decision-making for people with aphasia: an international cross-sectional survey.

Disability and rehabilitation·2026

Related Experiment Video

Updated: Nov 18, 2025

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices
07:57

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

Published on: April 11, 2018

7.1K

Primary Progressive Aphasia: Toward a Pathophysiological Synthesis.

Justina Ruksenaite1, Anna Volkmer2, Jessica Jiang1

  • 1Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, 8 - 11 Queen Square, London, WC1N 3BG, UK.

Current Neurology and Neuroscience Reports
|February 5, 2021
PubMed
Summary
This summary is machine-generated.

Primary progressive aphasia (PPA) involves early speech and language decline. Recent findings advance understanding of PPA pathophysiology, impacting diagnosis, care, and therapies for these challenging dementias.

Keywords:
Alzheimer’s diseaseFrontotemporal dementiaLogopenic aphasiaPhysiologyPrimary progressive aphasiaProgressive nonfluent aphasiaSemantic dementia

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.0K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.8K

Related Experiment Videos

Last Updated: Nov 18, 2025

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices
07:57

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

Published on: April 11, 2018

7.1K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.0K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.8K

Area of Science:

  • Neurology
  • Linguistics
  • Gerontology

Background:

  • Primary progressive aphasia (PPA) is a group of dementias characterized by early and significant speech and language impairments.
  • These neurodegenerative conditions pose substantial diagnostic and therapeutic challenges for clinicians and researchers.

Purpose of the Study:

  • To review critical issues in the diagnosis of major PPA variants (semantic, nonfluent/agrammatic, logopenic) and related syndromes.
  • To discuss disease staging, physiological phenotyping of proteinopathies, and central auditory impairments in PPA.
  • To outline treatment challenges and discuss pathophysiological features of PPA variants.

Main Methods:

  • Literature review focusing on diagnostic criteria for PPA variants.
  • Analysis of studies on disease progression and staging in PPA.
  • Examination of research on proteinopathies, auditory processing, and treatment strategies for PPA.

Main Results:

  • Elucidation of pathophysiology across the PPA spectrum offers new insights.
  • Identification of key challenges in PPA diagnosis, management, and therapy.
  • Evidence for core central auditory impairments in PPA is reviewed.

Conclusions:

  • Advances in understanding PPA pathophysiology are crucial for improving patient care.
  • Addressing remaining challenges in diagnosis, management, and treatment is essential.
  • New findings have significant implications for the future of PPA research and clinical practice.